SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Sunovion Pharmaceuticals Inc.'s Latuda® (lurasidone HCl) Label Updated With Expanded Dosing Range Providing Added Flexibility for the Treatment of Patients With Schizophrenia
Your Message